A detailed history of Icon Wealth Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Icon Wealth Partners, LLC holds 2,097 shares of AZN stock, worth $135,130. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,097
Holding current value
$135,130
% of portfolio
0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$64.85 - $71.7 $135,990 - $150,354
2,097 New
2,097 $142,000
Q3 2020

Oct 22, 2020

SELL
$53.07 - $61.1 $246,191 - $283,442
-4,639 Closed
0 $0
Q2 2020

Jul 14, 2020

BUY
$43.1 - $55.31 $199,940 - $256,583
4,639 New
4,639 $245,000
Q1 2020

Apr 17, 2020

SELL
$37.79 - $51.33 $153,918 - $209,067
-4,073 Closed
0 $0
Q4 2019

Jan 29, 2020

SELL
$42.46 - $50.46 $25,900 - $30,780
-610 Reduced 13.03%
4,073 $203,000
Q3 2019

Oct 24, 2019

SELL
$40.12 - $45.47 $12,316 - $13,959
-307 Reduced 6.15%
4,683 $209,000
Q2 2019

Aug 13, 2019

BUY
$37.28 - $41.68 $10,475 - $11,712
281 Added 5.97%
4,990 $206,000
Q1 2019

May 09, 2019

SELL
$35.49 - $43.02 $137,488 - $166,659
-3,874 Reduced 45.14%
4,709 $190,000
Q4 2018

Feb 14, 2019

SELL
$36.86 - $41.49 $94,951 - $106,878
-2,576 Reduced 23.08%
8,583 $326,000
Q3 2018

Nov 14, 2018

SELL
$34.76 - $39.72 $80,295 - $91,753
-2,310 Reduced 17.15%
11,159 $442,000
Q2 2018

Aug 13, 2018

SELL
$34.55 - $37.05 $58,804 - $63,059
-1,702 Reduced 11.22%
13,469 $473,000
Q1 2018

May 15, 2018

SELL
$32.97 - $36.63 $60,961 - $67,728
-1,849 Reduced 10.86%
15,171 $531,000
Q4 2017

Feb 13, 2018

BUY
$32.09 - $34.78 $546,171 - $591,955
17,020
17,020 $591,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Icon Wealth Partners, LLC Portfolio

Follow Icon Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Icon Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Icon Wealth Partners, LLC with notifications on news.